China Medical & HealthCare Group Limited
COLRF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $783 | $806 | $822 | $839 |
| % Growth | -2.8% | -1.9% | -2.1% | – |
| Cost of Goods Sold | $633 | $655 | $648 | $714 |
| Gross Profit | $150 | $151 | $174 | $125 |
| % Margin | 19.1% | 18.7% | 21.1% | 14.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $108 | $115 | $109 | $113 |
| SG&A Expenses | $112 | $128 | $112 | $116 |
| Sales & Mktg Exp. | $4 | $3 | $4 | $3 |
| Other Operating Expenses | $3 | -$1 | -$1 | $0 |
| Operating Expenses | $115 | $127 | $112 | $99 |
| Operating Income | $35 | $24 | $62 | $54 |
| % Margin | 4.5% | 3% | 7.5% | 6.4% |
| Other Income/Exp. Net | -$12 | -$13 | -$16 | -$21 |
| Pre-Tax Income | $24 | $11 | $46 | $33 |
| Tax Expense | $1 | -$2 | $17 | $13 |
| Net Income | $2 | $7 | $22 | $13 |
| % Margin | 0.2% | 0.9% | 2.6% | 1.6% |
| EPS | 0.001 | 0.007 | 0.02 | 0.012 |
| % Growth | -78.8% | -66.8% | 65.8% | – |
| EPS Diluted | 0.001 | 0.007 | 0.02 | 0.012 |
| Weighted Avg Shares Out | 1,084 | 1,086 | 1,086 | 1,086 |
| Weighted Avg Shares Out Dil | 1,084 | 1,086 | 1,086 | 1,086 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $21 |
| Depreciation & Amortization | $6 | $44 | $46 | $46 |
| EBITDA | $14 | $80 | $107 | $100 |
| % Margin | 1.7% | 9.9% | 13% | 11.9% |